Meeting Program
 |
To view program in "24 hour" time (international) click here. |
| Sunday, March 21 | ||
|---|---|---|
| 3:00 - 7:30 PM | Registration | Van Horne Foyer |
| 6:15 - 7:15 PM | Refreshments | Van Horne Foyer |
| 7:15 - 7:30 PM |
Orientation for New Attendees and New Investigators Registered attendees for this meeting can view Abstracts for this session starting on 02/21/2010 NOTE: Keystone Symposia's Chief Scientific Officer, Dr. Andy Robertson, to lead discussion in a "What to Expect during your Attendance" for interested delegates. |
Van Horne Ballroom |
| 7:30 - 9:30 PM |
Keynote Session (Joint) Registered attendees for this meeting can view Abstracts for this session starting on 02/21/2010 |
Van Horne Ballroom |
|
Bruce D. Walker,
Massachusetts General Hospital, USA
Durable Control of HIV Infection: Implications for Vaccine Design |
||
|
Peter C. Doherty,
University of Melbourne, Australia
Anti-Viral Immunity: Lessons from Influenza Virus |
||
| Monday, March 22 | ||
| 7:00 - 8:00 AM | Breakfast | Mezzanine 2 |
| 8:00 - 11:00 AM |
Adaptive Immunity/T- and B-Cell Responses Registered attendees for this meeting can view Abstracts for this session starting on 02/21/2010 |
Van Horne Ballroom A-B |
|
*
Marcus Altfeld,
Massachusetts General Hospital, USA
|
||
|
Kim J. Hasenkrug,
NIAID, National Institutes of Health, USA
T Cell and B Cell Memory in Protection against Mouse Retrovirus Infection |
||
|
Richard A. Koup,
National Institutes of Health, USA
Adaptive Immunity to HIV |
||
|
Barbara L. Shacklett,
University of California, Davis, USA
Mucosal Immune Responses to HIV Infection |
||
|
Barton F. Haynes,
Duke University Medical Center, USA
B-Cell Immune Responses to Acute HIV Infection |
||
|
Hendrik Streeck,
Massachusetts General Hospital, Harvard Medical School, USA
Short Talk: Increased Control of Viral Replication by HIV-1-Specific CD8+ T Cells Mediated by HIV-Specific CD4+ T Helper Signals |
||
| Following Session is for Viral Immunity (X6) | ||
| 8:00 - 11:15 AM |
Innate Recognition of Virus Infection Registered attendees for this meeting can view Abstracts for this session starting on 02/21/2010 |
Van Horne Ballroom C |
|
*
Herbert (Skip) W. Virgin IV,
Washington University School of Medicine, USA
|
||
|
Ruslan M. Medzhitov,
Yale University School of Medicine, USA
Innate Recognition of Endogenous Retroviruses |
||
|
Nelson Cesar Di Paolo,
University of Washington, USA
Short Talk: Adenovirus Binding to beta3 Integrins Activates Innate Antiviral Immunity Independently of the Virus DNA Recognition by Intracellular Sensors |
||
|
Michael J. Gale Jr.,
University of Washington, USA
Regulation of Pathogen Recognition Receptor Signaling and Innate Immunity by Hepatitis C Virus |
||
|
Thirumala-Devi Kanneganti,
St. Jude Children's Research Hospital, USA
NLRs in Innate Immunity to Influenza Virus |
||
|
Sammy Bedoui,
University of Melbourne, Australia
Short Talk: Priming of CD8 T Cell Immunity to Herpes Simplex Virus Type 1 Requires Cognate TLR3 Expression in vivo |
||
|
Akiko Iwasaki,
Yale University School of Medicine, USA
Toll Like Receptors in Viral Immunity |
||
| 9:20 - 9:40 AM | Coffee Break | Van Horne Foyer |
| 11:00 AM- | On Own for Lunch and Recreation | |
| 11:00 AM- 1:00 PM | Poster Setup | Mezzanine 2 |
| 1:00 - 10:00 PM | Poster Viewing | Mezzanine 2 |
| 1:00 - 2:30 PM |
Hands-on Computer Session on Los Alamos Sequence Database |
|
|
*
Brian T. Foley,
Los Alamos National Laboratory, USA
|
||
|
*
Bette T. Korber,
Los Alamos National Laboratory, USA
|
||
| 2:30 - 4:30 PM |
Workshop 1: Advances in Vaccine Development: Clinical Trials |
Van Horne Ballroom A-B |
|
*
M. Juliana McElrath,
Fred Hutchinson Cancer Research Center, USA
|
||
|
*
Nelson L. Michael,
Walter Reed Army Institute of Research, USA
RV 144 Update: Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thai Adults |
||
|
Jill Gilmour,
International AIDS Vaccine Initiative, UK
Induction of Viral inhibition in Clinical HIV Vaccine Trials of Diverse Immunogens |
||
|
Ruth M. Ruprecht,
Dana-Farber Cancer Institute, USA
Prevention of Systemic Infection by a Multigenic Recombinant Protein Vaccine after Heterologous R5 Clade C SHIV Challenge: Correlates of Protection |
||
|
Julia Rood,
National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA
HIV-Specific CD8+ T-cells of Vaccinees Exhibit Per-Cell Cytotoxic Capacity Comparable to Those of Progressors |
||
|
Erica Andersen-Nissen,
Fred Hutchinson Cancer Research Center, USA
Systemic Innate Immune Responses to a DNA/MVA Candidate HIV Vaccine |
||
|
William C. Adams,
Karolinska Institutet, Sweden
Adenovirus Type-35 Vectors Block Human CD4+ T Cell Activation by CD46 Ligation |
||
| 4:30 - 5:00 PM | Coffee Available | Van Horne Foyer |
| 5:00 - 7:00 PM |
Control of HIV Infection Registered attendees for this meeting can view Abstracts for this session starting on 02/21/2010 |
Van Horne Ballroom A-B |
|
*
Andrew J. McMichael,
John Radcliffe Hospital, UK
Vaccine Design: Lessons from Acute HIV-1 Infection |
||
|
R. Paul Johnson,
Harvard Medical School, USA
Lessons from Live Attenuated SIV |
||
|
Guido Silvestri,
University of Pennsylvania School of Medicine, USA
Nonpathogenic Natural SIV Infections |
||
|
Mark Brockman,
Simon Fraser University, Canada
Short Talk: Reduced Replication Capacity of Recombinant Viruses Encoding Acute/Early HIV-1 Gag-Protease Sequences from Individuals Expressing Protective HLA Class I Alleles |
||
| Following Session is for Viral Immunity (X6) | ||
| 5:00 - 7:00 PM |
Innate Immunity to Viruses Registered attendees for this meeting can view Abstracts for this session starting on 02/21/2010 |
Van Horne Ballroom C |
|
*
Akiko Iwasaki,
Yale University School of Medicine, USA
|
||
|
Herbert (Skip) W. Virgin IV,
Washington University School of Medicine, USA
'Virus-Host Susceptibility Gene' Interactions Control Chronic Inflammatory Disease |
||
|
Doris Wilflingseder,
Innsbruck Medical University, Austria
Short Talk: Complement as an Endogenous Adjuvant for Dendritic Cell-Mediated Induction of Retrovirus-Specific CTLs |
||
|
Ofer Mandelboim,
Hebrew University of Jerusalem, Israel
Cellular and Viral microRNAs Controlling Immune Response to Stress |
||
|
Wayne M. Yokoyama,
Washington University School of Medicine, USA
NK Cells, CTLs, and Virus Infection: Missing-Self in Action? |
||
| 7:00 - 8:00 PM | Social Hour w/ Lite Bites | Mezzanine 2 |
| 7:30 - 10:00 PM |
Poster Session 1 Registered attendees for this meeting can view Abstracts for this session starting on 02/21/2010 |
Mezzanine 2 |
| Tuesday, March 23 | ||
| 7:00 - 8:00 AM | Breakfast | Mezzanine 2 |
| 8:00 - 11:45 AM |
Neutralizing Antibody Registered attendees for this meeting can view Abstracts for this session starting on 02/21/2010 |
Van Horne Ballroom A-B |
|
Eric Hunter,
Emory University, USA
Recently Transmitted HIV and the Early Neutralizing Antibody Response |
||
|
Cynthia A. Derdeyn,
Emory University, USA
Recently Transmitted HIV and the Early Neutralizing Antibody Response |
||
|
Peter D. Kwong,
Vaccine Research Center, National Institutes of Health, USA
Antibody VRC01: To Be or Not To Be Like CD4 |
||
|
Quentin J. Sattentau,
Sir William Dunn School of Pathology, UK
Inducing Mucosal HIV-1 Antibodies in an Anti-Inflammatory Environment |
||
|
*
Lynn Morris,
National Institute for Communicable Diseases, South Africa
How Does Neutralization Breadth Develop in HIV Infection |
||
|
Ann J. Hessell,
The Scripps Research Institute, USA
Short Talk: A Non-Fucosylated Variant of the Anti-HIV-1 MAb b12 Results in Greatly Increased ADCC and ADCVI and Binds FcgammaRIIIa with Higher Affinity than Wild-Type b12 |
||
|
Joseph Joyce,
Merck & Co., Inc., USA
Short Talk: Vaccination with Peptide Mimetics of the gp41 Pre-Hairpin Fusion Intermediate Yields Neutralizing Antisera Against HIV-1 Isolates |
||
| Following Session is for Viral Immunity (X6) | ||
| 8:00 - 11:15 AM |
T-Cell Immunity to Viruses Registered attendees for this meeting can view Abstracts for this session starting on 02/21/2010 |
Van Horne Ballroom C |
|
*
Jack R. Bennink,
National Institutes of Health, USA
|
||
|
Nicole L. La Gruta,
University of Melbourne, Australia
Dissection of CTL Immunodominance Determinants Following Viral Infection |
||
|
Guna Karupiah,
John Curtin School of Medical Research, Australian National University, Australia
Short Talk: The Biological Significance of Proliferation-Independent Expansion of Antigen-Specific CD8+ T Cells through Receptor Sharing |
||
|
Andrea Lynn Cox,
Johns Hopkins University, USA
Analysis of T cells Chasing Hepatitis C Virus Escape Variants |
||
|
Ann B. Hill,
Oregon Health & Science University, USA
CD8+ T Cells and Cytomegalovirus: A Dangerous Obsession? |
||
|
Linda S. Cauley,
University of Connecticut Health Center, USA
Short Talk: Cause and Effects of Prolonged Lymph Node Hypertrophy after Influenza Infection |
||
|
J. Lindsay Whitton,
The Scripps Research Institute, USA
CD8+ T Cell Responses To Infection: A Tale Of Two Viruses |
||
| 9:20 - 9:40 AM | Coffee Break | Van Horne Foyer |
| 11:45 AM- | On Own for Lunch and Recreation | |
| 11:45 AM- 1:00 PM | Poster Setup | Mezzanine 2 |
| 1:00 - 10:00 PM | Poster Viewing | Mezzanine 2 |
| 1:00 - 2:30 PM |
Hands-on Computer Session on Los Alamos Sequence Database |
|
|
*
Brian T. Foley,
Los Alamos National Laboratory, USA
|
||
|
*
Bette T. Korber,
Los Alamos National Laboratory, USA
|
||
| 2:30 - 4:30 PM |
Workshop 2: Novel Vector and Adjuvant Development |
Van Horne Ballroom A-B |
|
*
Gerald H. Voss,
GlaxoSmithKline Biologicals, Belgium
|
||
|
John K. Rose†,
Yale University School of Medicine, USA
Strong Protection Against SIVsmE660 Mucosal Challenge Conferred by a Novel, Heterologous, Prime-Boost Vaccine Regimen |
||
|
Mauricio A. Martins,
University of Wisconsin-Madison, USA
Recombinant Yellow Fever Vaccine Virus 17D Expressing SIVmac239 Gag Induces SIV-Specific CD8+ T Cell Responses in Rhesus Macaques |
||
|
*
Nancy L. Haigwood,
Oregon Health and Science University, USA
Novel VLPs Rapidly Induce High Titer Neutralizing Antibodies when Combined with DNA Vaccines in Rabbits |
||
|
Adrian McDermott†,
International AIDS Vaccine Initiative, USA
Control of Pathogenic SIVmac239 Following Electroporated DNA + IL-12 Prime and Adenovirus 5 Boost in a Study Designed to Compare Priming Strategies in the NHP Model |
||
|
Magdalini Moutaftsi,
Infectious Disease Research Institute, USA
Glucopyranosyl Lipid A (GLA), a Synthetic TLR4 Vaccine Adjuvant, Induces Potent Th1-Promoting Immune Responses |
||
|
Anna Bershteyn,
Massachusetts Institute of Technology, USA
Versatile Lipid-Based Vaccine Carriers Elicit CTL and Antibody Responses to Surface-Conjugated or Encapsulated Antigen |
||
|
Ben Berkhout,
University of Amsterdam, Academic Medical Center, The Netherlands
Live Attenuated SIV: Characterising the Role of Vaccine Persistence in Protection |
||
|
Tomas Hanke,
Weatherall Institute of Molecular Medicine, UK
Long Peptides Induce Polyfunctional Macaque T Cells Against Conserved Regions of HIV-1 with Superior Breadth to Single-Gene Vaccines |
||
| Following Workshop is for Viral Immunity (X6) | ||
| 2:30 - 4:30 PM |
Workshop 1: Anti-Viral CD8 T Cell Responses Registered attendees for this meeting can view Abstracts for this session starting on 02/21/2010 |
Van Horne Ballroom C |
| Following Workshop is for Viral Immunity (X6) | ||
| 2:30 - 3:30 PM |
Workshop 1A: CD8 T Cell Memory Registered attendees for this meeting can view Abstracts for this session starting on 02/21/2010 |
|
|
*
Tania H. Watts,
University of Toronto, Canada
|
||
|
*
David C. Tscharke,
Australian National University, Australia
|
||
|
Jeffrey C. Nolz,
University of Iowa, USA
Multiple Antigen Encounters Decrease the Protective Capacity of the Ensuing Memory CD8 T Cell Population Against Chronic LCMV Infection |
||
|
John Rutigliano,
St. Jude Children's Research Hospital, USA
Development and Differentiation of Memory CD8+ T Cells in Influenza Infection |
||
|
Hélène Decaluwe,
Pasteur Institute, France
Gamma c Deficiency Precludes CD8+ T Cell Memory Despite Formation of Potent Anti-Viral T Cell Effectors |
||
|
Amol Suryawanshi,
University of Tennessee, USA
Galectin-9/TIM-3 Interaction Regulates Virus-Specific Primary and Memory CD8+T Cell Response |
||
| 4:30 - 5:00 PM | Coffee Available | Van Horne Foyer |
| 5:00 - 7:00 PM |
Innate Immunity Registered attendees for this meeting can view Abstracts for this session starting on 02/21/2010 |
Van Horne Ballroom A-B |
|
*
Bali Pulendran,
Emory University, USA
|
||
|
Marcus Altfeld,
Massachusetts General Hospital, USA
Natural Killer Cells in HIV-1 Infection |
||
|
Mariapia A. Degli-Esposti,
LEI, University of Western Australia, Australia
NK/DC Crosstalk and Regulation of Adaptive Immunity |
||
|
Jay A. Berzofsky,
National Cancer Institute, National Institutes of Health, USA
Short Talk: Innate and Adaptive Immune Correlates of Vaccine-Induced Control of Mucosal Transmission of SIV in Macaques |
||
|
Silke Paust,
Harvard Medical School, USA
Short Talk: Critical Role for CXCR6 in NK Cell Mediated Adaptive Immunity to Viruses |
||
|
Veronica Anna Sofia Tjomsland,
University of Linköping, Sweden
Short Talk: Receptors and Pathways Utilized by Dendritic Cells for Antigen Presentation of Free and Complement Opsonized HIV |
||
| Following Session is for Viral Immunity (X6) | ||
| 5:00 - 7:00 PM |
Routes of Antigen Presentation Registered attendees for this meeting can view Abstracts for this session starting on 02/21/2010 |
Van Horne Ballroom C |
|
*
Nicole L. La Gruta,
University of Melbourne, Australia
|
||
|
William R. Heath,
University of Melbourne, Australia
Viral Antigen Presentation to Naïve and Memory CD8+ T Cells |
||
|
Margarita Del Val,
Instituto de Salud Carlos III, Spain
Short Talk: Furin-Processed Antigens Targeted to the Secretory Route Elicit Functional TAP1-/- CD8+ T Lymphocytes in vivo |
||
|
Sylvie Le Gall,
Massachusetts General Hospital, Harvard Medical School, USA
Deciphering HIV Epitope Production: Implications for Immunogen Design |
||
|
Laurence C. Eisenlohr,
Thomas Jefferson University, USA
A Proteasome- and TAP-Dependent MHC Class II-Restricted Presentation Pathway that Stimulates a Substantial Portion of the Antiviral CD4+ T Cell Response: Part 2 |
||
| 7:00 - 8:00 PM | Social Hour w/ Lite Bites | Mezzanine 2 |
| 7:30 - 10:00 PM |
Poster Session 2 Registered attendees for this meeting can view Abstracts for this session starting on 02/21/2010 |
Mezzanine 2 |
| Wednesday, March 24 | ||
| 7:00 - 8:00 AM | Breakfast | Mezzanine 2 |
| 8:00 - 11:15 AM |
Vaccines: Immunologic Mechanisms of Action (Joint) Registered attendees for this meeting can view Abstracts for this session starting on 02/21/2010 |
Van Horne Ballroom |
|
*
Kim J. Hasenkrug,
NIAID, National Institutes of Health, USA
|
||
|
Bali Pulendran,
Emory University, USA
Lessons from Yellow Fever Vaccine |
||
|
Ian H. Frazer,
University of Queensland, Australia
Lessons from Human Papillomavirus Vaccines |
||
|
Shane Crotty,
La Jolla Institute for Allergy and Immunology, USA
Lessons from the Smallpox Vaccine: Follicular Helper CD4+ T Cell (Tfh) Differentiation and Neutralizing Antibodies |
||
|
M. Juliana McElrath,
Fred Hutchinson Cancer Research Center, USA
Lessons from the STEP Trial and the Current Clinical Pipeline |
||
|
Mark Stephen de Souza,
AFRIMS, Thailand
Short Talk: Immunogenicity of the Thai Phase III (RV144) HIV Vaccine Regimen |
||
|
Monica Vaccari†,
National Cancer Institute, USA
Short Talk: HIV/SIV Vaccine Efficacy Dependent on the Dose of SIVmac251 Challenge Exposure in Macaques |
||
| 9:20 - 9:40 AM | Coffee Break | Van Horne Foyer |
| 11:15 AM- | On Own for Lunch and Recreation | |
| 11:15 AM- 1:00 PM | Poster Setup | Mezzanine 2 |
| 1:00 - 10:00 PM | Poster Viewing | Mezzanine 2 |
| 4:30 - 5:00 PM | Coffee Available | Van Horne Foyer |
| 5:00 - 7:00 PM |
Imaging of the Antiviral Immune Response (Joint) Registered attendees for this meeting can view Abstracts for this session starting on 02/21/2010 |
Van Horne Ballroom |
|
*
Jonathan W. Yewdell,
National Institutes of Health, USA
|
||
|
Heather D. Hickman,
DHHS, NIH, NIAID, USA
Intravital Imaging of the CD8+ T Cell Response to Virus |
||
|
Ronald N. Germain,
NIAID, National Institutes of Health, USA
Intravital Imaging of Adaptive Immune Effector Activity |
||
|
Matteo Iannacone,
Harvard Medical School, USA
Short Talk: Lymph Node Subcapsular Sinus Macrophages Confer Resistance to CNS Invasion Upon Peripheral Infection With a Neurotropic Virus |
||
|
Ashley T. Haase,
University of Minnesota, USA
In Vivo Imaging of the Cellular Immune Response to Viral Infections |
||
| 7:00 - 8:00 PM | Social Hour w/ Lite Bites | Mezzanine 2 |
| 7:30 - 10:00 PM |
Poster Session 3 Registered attendees for this meeting can view Abstracts for this session starting on 02/21/2010 |
Mezzanine 2 |
| Thursday, March 25 | ||
| 7:00 - 8:00 AM | Breakfast | Mezzanine 2 |
| 7:00 - 11:00 AM | Poster Setup | Mezzanine 2 |
| 8:00 - 11:15 AM |
Novel Vaccine Approaches Registered attendees for this meeting can view Abstracts for this session starting on 02/21/2010 |
Van Horne Ballroom A-B |
|
Wayne C. Koff,
International AIDS Vaccine Initiative, USA
Future Directions in AIDS Vaccine Development |
||
|
Gerald H. Voss,
GlaxoSmithKline Biologicals, Belgium
AS01, an Adjuvant System Potentiating Vaccines against Complex Pathogens |
||
|
Bette T. Korber,
Los Alamos National Laboratory, USA
HIV Antigen Designs to Address HIV Variability |
||
|
*
Louis J. Picker,
Oregon Health & Science University, USA
Cytomegalovirus Vectors |
||
|
Dan H. Barouch,
Beth Israel Deaconess Medical Center, USA
Short Talk: Heterologous Rare Serotype Adenovirus Vectors for HIV-1 + |
||
|
Brad Jones,
University of Toronto, Canada
Short Talk: Comprehensive Elimination of Globally Diverse HIV Primary Isolate Infections by HERV-K-Specific CD8+ T Cells |
||
| Following Session is for Viral Immunity (X6) | ||
| 8:00 - 11:15 AM |
Immunity to Chronic and Persistent Viral Infections Registered attendees for this meeting can view Abstracts for this session starting on 02/21/2010 |
Van Horne Ballroom C |
|
*
Peter C. Doherty,
University of Melbourne, Australia
|
||
|
Marcia A. Blackman,
Trudeau Institute, USA
Immune Control of Gamma-Herpesvirus Latency |
||
|
Ilhem Messaoudi,
Oregon Health & Science University, USA
Short Talk: Elucidating the Role of T Cell Immunity in the Control of VZV Replication using a Novel Nonhuman Primate Model |
||
|
Emmanuel J. Wiertz,
University Medical Center Utrecht, The Netherlands
Herpesvirus Interference with T-Cell Immunity |
||
|
Elina I. Zuniga,
University of California, San Diego, USA
Short Talk: Sustained-Cell-Intrinsic Transforming Growth Factor-beta Signaling Mediates Virus-Specific CD8+ T Cell Deletion and Viral Persistence in vivo |
||
|
Barbara Rehermann,
National Institutes of Health, USA
Immunity to Hepatitis C Virus |
||
|
Francis V. Chisari,
The Scripps Research Institute, USA
Induction and Evasion of the Innate Host Response to HCV |
||
| 9:20 - 9:40 AM | Coffee Break | Van Horne Foyer |
| 11:15 AM- 1:00 PM | Lunch | Mezzanine 2 |
| 12:00 - 2:30 PM |
Poster Session 4 Registered attendees for this meeting can view Abstracts for this session starting on 02/21/2010 |
Mezzanine 2 |
| 2:30 - 4:30 PM |
Workshop 3: HIV Pathogenesis to Inform Vaccine Design |
The Theatre |
|
*
David I. Watkins,
University of Wisconsin-Madison, USA
|
||
|
*
Barbara L. Shacklett,
University of California, Davis, USA
|
||
|
Srinika R.F. Ranasinghe,
Weatherall Institute of Molecular Medicine, UK
The Antiviral Efficacy of HIV-specific CD8+ T-cells to a Conserved Epitope is Heavily Dependent on the Infecting HIV-1 Isolate |
||
|
Anne-Sophie M. Dugast,
Ragon Institute, Massachusetts General Hospital, USA
Significant Impairment in Innate Immune Cells Recruitment by Chronic Untreated Antibodies to Mediate ADCC |
||
|
Matthew R. Reynolds,
University of Wisconsin-Madison, USA
Macaques Vaccinated with SIVmac239∆nef Delay Acquisition and Control Replication after Repeated Low Dose Heterologous SIV Challenge |
||
|
Todd M. Allen,
Massachusetts General Hospital, USA
Ultra-Deep Sequencing During Acute HIV Infection Reveals the Earliest Adaptive Changes to Host Selection Pressures |
||
|
Qingsheng Li,
University of Minnesota, USA
Maturation of Virus-specific Antibodies in Cervicovaginal Tissues in SIVmac239∆nef-vaccinated Macaques |
||
|
Suzanne English,
University of Oxford, UK
Sexual Transmission of Highly-Distinct HIV-1 Variants from a Single Donor to Two Recipients on the Same Night: Divergent Immune-Recognition and Clinical Outcomes |
||
|
Suresh Pallikkuth,
University of Miami, USA
Recombinant IL-21 Induces Cytotoxic Molecule Granzyme B in Lymph Nodes of Chronic SIV Infected Rhesus Macaques |
||
|
Adam D. Burgener,
National Microbiology Lab, Canada
HIV-1-Resistant Sex Workers Overexpress Novel Antiproteases and Antiviral Factors in their Cervical Mucosa. Protective Milieu Against HIV-1 Infection? |
||
| Following Workshop is for Viral Immunity (X6) | ||
| 2:30 - 4:30 PM |
Workshop 2: Anti-Viral T and B-Cells and Viral Evolution Registered attendees for this meeting can view Abstracts for this session starting on 02/21/2010 |
Van Horne Ballroom C |
| Following Workshop is for Viral Immunity (X6) | ||
| 2:30 - 3:30 PM |
Workshop 2A: Anti-Viral CD4 and CD8 T Cell Responses Registered attendees for this meeting can view Abstracts for this session starting on 02/21/2010 |
|
|
*
Connie C. Bergmann,
Cleveland Clinic Foundation, USA
|
||
|
*
Kevin L. Legge†,
University of Iowa Carver College of Medicine, USA
|
||
|
Anna Haas,
Swiss Federal Institute of Technology, Switzerland
HIV-1 Replication Activates CD4+ T Cells with Specificities for Persistent Herpes Viruses |
||
|
Mickael J. Ploquin,
National Institute for Medical Research, UK
B Cells Shape the T Helper Response to Retroviral Infection |
||
|
David E. Verhoeven,
University of Maryland at Baltimore, USA
Memory CD4+ T-Cells Mediate Enhanced Immunopathology during Influenza Infection |
||
|
Jennifer Bomberger,
Dartmouth Medical School, USA
The Pseudomonas aeruginosa Toxin Cif Reduces MHC Class I Antigen Presentation and Viral Immunity |
||
| Following Workshop is for Viral Immunity (X6) | ||
| 2:30 - 3:30 PM |
Workshop 3: Innate Immunity to Virus Infection Registered attendees for this meeting can view Abstracts for this session starting on 02/21/2010 |
Van Horne Ballroom A-B |
| Following Workshop is for Viral Immunity (X6) | ||
| 2:30 - 3:30 PM |
Workshop 3A: Immunity to Viruses Registered attendees for this meeting can view Abstracts for this session starting on 02/21/2010 |
|
|
*
Adolfo Garcia-Sastre,
Mount Sinai School of Medicine, USA
|
||
|
Maulik Patel,
Fred Hutchinson Cancer Research Center, USA
Evolution as a Guide to Molecular Mechanisms of Pathogen Resistance |
||
|
Helene Minyi Liu,
University of Washinton, Seattle, USA
RIG-I Membrane-Association Controls Innate Antiviral Immunity |
||
|
Alina Baum,
Mount Sinai School of Medicine, USA
Characterization of Endogenous RIG-I Substrates from Virus Infected Cells |
||
|
Irving Coy Allen,
University of North Carolina at Chapel Hill, USA
NLRX1 is a Regulator of the Innate Immune Response to Influenza A Virus Infection |
||
| 4:30 - 5:00 PM | Coffee Available | Van Horne Foyer |
| 5:00 - 7:00 PM |
Antigenic Variation (Joint) Registered attendees for this meeting can view Abstracts for this session starting on 02/21/2010 |
Van Horne Ballroom |
|
*
Wayne C. Koff,
International AIDS Vaccine Initiative, USA
|
||
|
David I. Watkins,
University of Wisconsin-Madison, USA
The Effect of Vaccine-Induced SIV-Specific Immune Response on Viral Acquisition and Replication |
||
|
Arnaud Moris,
UPMC - Hôpital Pitié-Salpêtrière, France
Short Talk: The Antiviral Factor APOBEC3G Improves CTL Recognition of HIV-Infected T Cells: Linking Intrinsic and Adaptive Immune Responses |
||
|
Dennis R. Burton,
The Scripps Research Institute, USA
HIV Env and Approaches to Neutralizing Abs |
||
|
Jonathan W. Yewdell,
National Institutes of Health, USA
Still Drifting: Mechanisms of Influenza A Virus Hemagglutinin Immune Escape |
||
| 7:00 - 8:00 PM | Social Hour w/ Lite Bites | Mezzanine 2 |
| 8:00 - 11:00 PM | Entertainment | Mezzanine 2 |
| Friday, March 26 | ||
| Departure | ||
| *=Session Chair †=Speaker invited, not yet responded. | ||
Keystone Symposia would like to thank the sponsor of this meeting for their generous support:
We gratefully acknowledge additional support for this conference from:
|
GlaxoSmithKline Biologicals S.A.
|
These generous unrestricted gifts allow our Directors to schedule meetings in a wide variety of important areas, many of which are in the early stages of research.
Click here to view all of the donors who support the Directors' Fund.
We gratefully acknowledge the organizations that provide Keystone Symposia with additional support, such as marketing and advertising...
Click here to view these companies